Deferred Income Tax Liabilities, Net of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary: RECURSION PHARMACEUTICALS, INC. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
RECURSION PHARMACEUTICALS, INC. Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $23,312,000, a 13776% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Income Tax Liabilities, Net, Quarterly (USD)

Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$23,312,000	+$23,144,000	+13776%	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$23,784,000	+$23,784,000		30 Jun 2025	10-Q	05 Aug 2025	2025	Q2
Q1 2025	$22,437,000	+$21,909,000	+4149%	31 Mar 2025	10-Q	05 May 2025	2025	Q1
Q4 2024	$16,575,000	+$15,236,000	+1138%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$168,000	-$1,763,000	-91%	30 Sep 2024	10-Q	06 Nov 2024	2024	Q3
Q2 2024	$0	-$4,336,000	-100%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$528,000			31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$1,339,000	+$1,339,000		31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q3 2023	$1,931,000			30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$4,336,000			30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q4 2022	$0			31 Dec 2022	10-K	29 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.